Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelevant Articles
Thorax 2005;60:525
© 2005 BMJ Publishing Group Ltd & British Thoracic Society

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.


FEV1 AND RISK OF LUNG CANCER
As Wasswa-Kintu and colleagues point out in their paper in this issue of Thorax, 328 million people died of lung cancer in the world in the year 2000 and lung cancer is the most lethal cancer in the world. Patients with markedly reduced lung function have a higher risk of lung cancer and, in this month’s Thorax, these authors investigate in a systematic review whether milder reductions in FEV1 are also associated with an increased risk from lung cancer. When the highest quintile of FEV1 (>100% predicted) was compared with the lowest quintile (<70% predicted), the lowest quintile was associated with an increased risk of lung cancer in men and particularly in women. The authors also found that women were twice as likely as men to develop lung cancer for the same marginal decrements in FEV1. These results have important implications for studies of screening for early . . . [Full text of this article]


Relevant Articles

Creatine supplementation as an exercise performance enhancer for patients with COPD? An idea to run with
T L Griffiths and D Proud
Thorax 2005 60: 525-526. [Extract] [Full Text] [PDF]

Smoking and tuberculosis: a chance or causal association?
G H Bothamley
Thorax 2005 60: 527-528. [Extract] [Full Text] [PDF]

Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease
J P Fuld, L P Kilduff, J A Neder, Y Pitsiladis, M E J Lean, S A Ward, and M M Cotton
Thorax 2005 60: 531-537. [Abstract] [Full Text] [PDF]

Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area
S den Boon, S W P van Lill, M W Borgdorff, S Verver, E D Bateman, C J Lombard, D A Enarson, and N Beyers
Thorax 2005 60: 555-557. [Abstract] [Full Text] [PDF]

Genotype-phenotype correlation for pulmonary function in cystic fibrosis
J de Gracia, F Mata, A Álvarez, T Casals, S Gatner, M Vendrell, D de la Rosa, L Guarner, and E Hermosilla
Thorax 2005 60: 558-563. [Abstract] [Full Text] [PDF]

Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis
S Wasswa-Kintu, W Q Gan, S F P Man, P D Pare, and D D Sin
Thorax 2005 60: 570-575. [Abstract] [Full Text] [PDF]

Recovery of the ciliated epithelium following acute bronchiolitis in infancy
J Y W Wong, A Rutman, and C O’Callaghan
Thorax 2005 60: 582-587. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society